Stephen Bloch

Axial Exchange Inc./old/ develops and publishes patient care and engagement software. Its features include care teams, wellness programs, activities, health trackers, medication management and push notification. The company was founded by Joanne Rohde and Mark Ragusa in 2009 an is headquartered in Raleigh, NC.

Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA.

Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC.

Truveris, Inc. provides health information technology services. It products include TruGuard is a proprietary technology validates claim payment accuracy, ensures regulatory compliance, and manages pharmacy spend. The company was founded by Leon Greene, Anthony J. Loiacono, Thomas Andrew Staloch, Kristin Begley and Justin E. Greene in 2008 and is headquartered in New York, NY.

Crossroads Venture Group, Inc. provides investment advisory services. The firm assists in the development of growth enterprises through the promotion of capital formation in Connecticut. The company is headquartered in East Hartford, CT.

Genome Medical Holding Co. operates tele genomics platform which allows genetic experts to consult with patients and physicians across the country. The firm specializes in genomics, genetics, precision medicine, medical practice, personalized medicine, genetic counseling, DNA and genome. The company was founded by Lisa J. Alderson, Robert C. Green and Randal W. Scott in 2016 and is headquartered in South San Francisco, CA.

EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT.

Iantrek Inc provides biotechnology services. The company is headquartered in White Plains, NY.

Allyx Therapeutics is an American clinical-stage biotechnology company founded in 2019 by a group of experienced biopharma industry executives, venture capitalists, and scientific experts. The company is based in an undisclosed location and aims to deliver a novel approach to preserve and protect synapses for people living with neurodegenerative diseases. Its lead compound, alx-001, is a first-in-class oral therapy with a unique mechanism of action at mglur5 currently in clinical development in Alzheimer's disease. The company is developing an oral drug that demonstrates reversal of learning and memory deficits due to Alzheimer's disease. The company was founded by Timothy Siegert, Stephen M. Bloch, Paul R. Fonteyne, and Stephen M. Bloch has been the CEO since incorporation.

Onkos Surgical, Inc. provides surgical oncology solutions. It delivers implants and instruments that meet the needs of musculoskeletal tumor patients. The company was founded by Patrick Treacy, Antony Koblish and Adele Oliva in 2015 and is headquartered in Parsippany, NJ.